A health-care industry rivalry has emerged in the cancer treatment market on Long Island among two major hospital groups, a business magazine report says.
The competition is between the North Shore-Long Island Jewish Health System and the Memorial Sloan-Kettering Cancer Center.
North Shore LIJ last year saw 16,489 cancer patients and "currently has 125 active clinical trials for children and adults" covering most tumor types, the Crain's New York Business report says.
The Crain's report notes that Sloan-Kettering is adding a new facility in Westchester, adding to a network that includes locations in Commack, Hauppauge and Rockville Centre.
North Shore LIJ says it has an advantage because its system hospitals are closer to Long Island residents for surgery and follow-up care.
"But Memorial Sloan-Kettering's position is that they attract patients who would have bypassed local facilities anyway, sparing them the trek," the report says.